Finding 611113 (2022-002)

- Repeat Finding
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2023-08-30

AI Summary

  • Core Issue: The Association missed deadlines for submitting quarterly and final reports required by grant agreements.
  • Impacted Requirements: Reports were due 15 days after each quarter and after grant closure; 3 out of 4 quarterly reports and the final report were late.
  • Recommended Follow-Up: Ensure all future grant reports are completed and submitted on time to maintain compliance.

Finding Text

Condition: The Association did not timely submit certain quarterly and final reports required by certain grant agreements to the grantor by the required submission due dates. Criteria: The Association?s grant agreements require quarterly reconciliation reports to be filed with the grantor 15 days after the conclusion of the quarter. For the year ended June 30, 2022 we noted 3 of the 4 reports due during the year were filed past the required 15 day due dates. Additionally, upon the conclusion of a grant, the Association?s grant agreements required the filing of a sworn statement of expenditures report, which was due within 15 days after the grant closed. For the year ended June 30, 2022, we tested the one required sworn statement of expenditures report that was required to be filed, which was filed past the required 15 day due date. Cause: The Association failed to timely file certain grant reporting documents that were tested during the audit prior to the submission deadlines for the year ended June 30, 2022. Effect: The Association was not in compliance with the requirements of their grant agreement. Questioned Costs: N/A Recommendation: We recommend the Association complete and submit all future required grant reports prior to the required deadline to ensure all compliance requirements are met. Views of Responsible Officials: Management concurs with the finding and has developed a plan to correct the finding.

Categories

Reporting

Other Findings in this Audit

  • 34671 2022-002
    - Repeat
  • 34672 2022-003
    - Repeat
  • 34673 2022-004
    Significant Deficiency Repeat
  • 34674 2022-001
    - Repeat
  • 34675 2022-001
    - Repeat
  • 34676 2022-002
    - Repeat
  • 34677 2022-003
    - Repeat
  • 34678 2022-004
    Significant Deficiency Repeat
  • 611114 2022-003
    - Repeat
  • 611115 2022-004
    Significant Deficiency Repeat
  • 611116 2022-001
    - Repeat
  • 611117 2022-001
    - Repeat
  • 611118 2022-002
    - Repeat
  • 611119 2022-003
    - Repeat
  • 611120 2022-004
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $1.12M